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Abstract
Preimplantation embryo development involves four stages: fertilization, cell cleavage, morula and
blastocyst formation. During these stages, maternal and zygotic epigenetic factors play crucial roles.
The gene expression profile is changed dramatically, chromatin is modified and core histone
elements undergo significant changes. Each preimplantation embryo stage has its own characteristic
epigenetic profile, consistent with the acquisition of the capacity to support development.
Moreover, histone modifications such as methylation and acetylation as well as other epigenetic
events can act as regulatory switches of gene transcription. Because the epigenetic profile is largely
related to differentiation, epigenetic dysfunction can give rise to developmental abnormalities.
Thus, epigenetic profiling of the embryo is of pivotal importance clinically. Given the importance of
these aspects, this review will mainly focus on the epigenetic profile during preimplantation embryo
development, as well as interactions between epigenetic and genetic regulation in these early
developmental stages.
Background
Starting from fertilization and ending with implantation,
preimplantation embryo development can be divided
into several well-orchestrated stages: fertilization, cell
cleavage, morula and blastocyst formation. Understand-
ing the stages of preimplantation development and the
underlying regulatory molecular mechanisms is of pivotal
importance for basic reproductive biology and for practi-
cal applications including regenerative medicine. To deci-
pher the regulatory mechanisms, determining the global
gene, RNA and protein expression patterns of early
embryo is indispensable. Early attempts to do this pro-
vided data on protein expression patterns using compara-
tive electrophoretic analysis with radiolabeled tyrosine
and lysine [1] and RNA expression patterns were esti-
mated using cDNA library analysis [2]. A series of subse-
quent studies reported modified or novel methods
including polymerase chain reaction (PCR)-based differ-
ential display [3] and subtractive cDNA library construc-
tion techniques [4]. With the development of microarray
technology, microarray analysis soon became one of the
most powerful approaches, providing more comprehen-
sive and precise global expression pattern data, especially
on gene expression profiles [5-7]. Based on transitions in
gene expression patterns in mouse embryos, preimplanta-
tion development can also be divided into several phases:
phase I from fertilization to the 2-cell stage; phase II from
the 4-cell to the 8-cell stage and phase III from the 8-cell
embryo to the blastocyst stage. Phases I and II can also be
called zygotic genome activation (ZGA) and mid-preim-
plantation gene activation, respectively [8]. At ZGA, some
proteins originally formed in the stage of oogenesis
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remain after fertilization and contribute to the regulation
of the next developmental processes.
Preimplantation embryo development is regulated both
genetically and epigenetically. Based on the knowledge of
genetic profiles, studies proceeded to elucidate epigenetic
profiles in embryogenesis and their particular contribu-
tions to genetic changes. Epigenetics refers to a collection
of mechanisms and phenomena that can cause a change
in the phenotype of a cell or an organism without altering
its DNA sequence [9]. DNA methylation, histone modifi-
cations, chromatin remodeling and various types of inter-
fering RNA (RNAi) are all involved. These epigenetic
events constitute a particular signature for each cell. Dur-
ing development, the epigenetic signature changes as the
cell enters a special activity (e.g. differentiation or fertili-
zation). Early studies focused largely on the effects of
DNA methylation [10,11] and the regulation of histone
modifications [12,13] on preimplantation embryo devel-
opment. Further studies have added chromatin organiza-
tion (core histone variants) [14] to this epigenetic
regulation network, making it more complex, intriguing
and – more importantly – making the start of life more
mysterious and beautiful.
Epigenetic regulation
The mature spermatozoon and oocyte acquire specific and
different epigenetic marks during gametogenesis. Besides
imprints, in the spermatozoon somatic linker histones are
replaced by testis-specific variants and then most histones
are replaced with protamines [15] whereas in the oocyte
the level of H3 lysine(K)4me3 may be higher because of
the enter of meiosis [16]. Parental imprints derived from
gametogenesis are retained faithfully in the zygote as well
as some other marks. However, others are reprogrammed
dynamically to meet the need of becoming totipotent. As
development proceeds, epigenetic marks undergo repro-
gramming again to adopt embryo to be fit for further dif-
ferentiation. Epigenetic reprogramming includes DNA
methylation, histone modifications and the formation of
histone variants.
DNA methylation
DNA methylation is a covalent chemical modification of
DNA, which transfers the methyl group of the coenzyme
S-adenosyl-L-methionine to cytosine residues of CpG
dinucleotides and is one of the main epigenetic events
[17]. To estimate the DNA methylation state, many detec-
tion methods have been developed. Methylated
sequences can be differentiated by sodium bisulfate DNA
modification or methylation-sensitive restriction enzyme
digestion, followed by PCR or hybridization methods
(Southern blotting and microarrays). Recently, there has
been more focus on genome-wide DNA methylation pro-
filing, which is determined by microarrays, high-perform-
ance liquid chromatography (HPLC) and restriction
landmark genomic scanning (RLGS) [18]. Based on these
technologies, the first high-resolution DNA methylation
profile of Arabidopsis thaliana genome has now been
determined [19], opening the way for 'methylomics'.
DNA methylation is an important epigenetic event, regu-
lating chromatin structure and gene expression in many
developmental processes including gene imprinting, X
chromosome inactivation and embryogenesis [20]. To
maintain or establish methylated DNA, DNA methyl-
transferases (Dnmts) are indispensable [21]. These can be
divided into three classes: Dnmt1, Dnmt2 and Dnmt3
(containing three subclasses Dnmt3a, Dnmt3b and
Dnmt3l). Dnmt1 is the main methyltransferase by far and
its exceptional preference for hemimethylated DNA indi-
cates its role in the maintenance of methylated status dur-
ing DNA replication. Dnmt2 is a methyltransferase but its
function is obscure and controversial. Dnmt3a and
Dnmt3b are both involved in de novo methylation proc-
esses but with different preferences. Thus, Dnmt3a prefers
to act on unmethylated DNA while Dnmt3b can assume
its role on both hemimethylated and unmethylated DNA.
Dnmt3l is devoid of enzymatic activity, although its role
as a regulator of proper methylation is still pivotal [21,22]
During preimplantation stages in embryogenesis, DNA
methylation experiences dynamic changes. In the mouse
embryo, the paternal and maternal pronuclei (PN) are
formed following fertilization. There is active demethyla-
tion in the paternal PN [23], whereas DNA is passively
demethylated during the later cleavage stages for the
entire genome [24]. The embryo then undergoes the first
cell differentiation process, accompanied by de novo
DNA methylation, which gives rise to stable silencing of
genes related to the maintenance of pluripotency [25].
The level of methylation in the inner cell mass (ICM) of
the blastocyst is higher than that in the outside cells, cor-
responding to different cell fates: the ICM will differenti-
ate into somatic cell lineages whereas the outer cells will
form the placenta (see reviews [26,27]) (Fig. 1A). How-
ever, these methylation changes do not always tell the
same story. Even in laboratory mice, variations may arise
[28], probably caused by inherent genotypic variability.
Moreover, this general model is also challenged by con-
troversial data obtained from other mammals including
the sheep [29], rabbit [30] and human [31]. This suggests
two possibilities: the first is that there is no functional rel-
evance between methylation changes and development;
the second is that such methylation changes are species-
specific and no general rule can be drawn. However, we
should still endeavor to confirm either of them, or put for-
ward alternative models.Reproductive Biology and Endocrinology 2009, 7:59 http://www.rbej.com/content/7/1/59
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Despite the dramatic changes in global methylation lev-
els, the methylation status of imprinted genes must
remain. A recent study showed that Dnmt3a and Dnmt3b
are dispensable for the maintenance of DNA methylation
status during embryonic cleavage stages and Dnmt1 alone
is sufficient to accomplish the job at most of the
imprinted loci except for the Rasgrf1 differentially meth-
ylated region (DMR) [32]. Dnmt1s, an isoform of Dnmt1,
was found to be present in association with chromatin in
the nucleus throughout preimplantation development
and was related to the maintenance of methylation in par-
ticular genomic regions such as repetitive intracisternal A-
type particle (IAP) sequences and the H19 imprinted
locus [33]. Zfp57, a maternal zygotic effect gene, has also
been found to be related to the maintenance of both
maternal and paternal imprints [34].
Methylation alterations also flourish at levels besides glo-
bal changes. Dnmt1o, another isoform of Dnmt1, is
expressed predominantly during oogenesis and early pre-
implantation development. Dnmt1o has a tissue-depend-
ent DMR (T-DMR) and its DNA methylation status
changes stage-by-stage. Thus Dnmt1o, as a participant in
the epigenetic processes, is also influenced by methylation
in terms of its expression level [35]. Moreover, analysis of
mRNA expression patterns of methyltransferases, methyl-
cytosine-binding proteins for chromatin modification
and base excision repair enzymes (which might in turn be
involved in active demethylation) [36] showed that even
within one embryo, different cells can show divergent
expression patterns. In other words, their epigenetic pro-
files differ from each other. This complicates the analysis
further, as now even single cells need to be given their
General view of the main epigenetic reprogramming pathways in preimplantation development Figure 1
General view of the main epigenetic reprogramming pathways in preimplantation development. (A) DNA meth-
ylation reprogramming in the mouse embryo. Active demethylation happens in paternal PN(pronucleus) followed by passive 
demethylation of the entire genome during cleavage stage. Then comes de novo methylation when the embryo commences cell 
differentiating. (B) Histone modification reprogramming, from fertilization to syngamy. In the paternal PN, sperm nuclear pro-
tamines are gradually replaced by highly acetylated histones, which are immediately substituted by monomethylated ones. 
Dimethylated and trimethylated histones appear later. In the maternal PN, all the modifications listed can be detected in this 
period. H3K9me3 is found in centromeric major satellites, whereas H3K9me2 is found in minor satellites.Reproductive Biology and Endocrinology 2009, 7:59 http://www.rbej.com/content/7/1/59
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own 'identity card'. Global analysis can show the situation
in an average level, but it overlooks the regional specifi-
city. DNA methylation profiling of a single cell might
show additional information and give indications of its
fate in differentiation.
DNA methylation is an important and irreplaceable event
in preimplantation development. It undergoes dynamic
changes not only globally but also in region-specific or
locus-specific manners. Furthermore, different cells in a
same embryo were found to possess different expression
patterns of methylation-related genes, indicating the
importance of the construction of single-cell-specific pro-
filing besides that of entire embryos. Analyzing the meth-
ylome may help to provide more data about temporal
and/or spatial DNA methylation status and complete the
story of DNA methylation reprogramming.
Histone modifications and chromatin remodeling
Histone modification is another covalent modification
that is involved in the regulation of gene expression. His-
tone modifications include acetylation, methylation,
phosphorylation, ubiquitylation and sumoylation [37].
These can be divided into two groups: small chemical
groups involving the first three processes, and much larger
peptide groups involving the latter two [38]. Besides
acetylation and methylation, other modifications may
also have their peculiar roles in preimplantation develop-
ment [39,40]. However, acetylation and methylation may
be more ubiquitous, so more focus is put on these proc-
esses and changes in their status during development have
been delineated clearly [26]. Additionally, histone modi-
fication also interacts with DNA methylation to produce
further epigenetic regulation. Suv39h1 histone methyl-
transferase (HMTase) directed H3K9 trimethylation was
shown to be required for recruiting Dnmt3b-dependent
DNA methylation to pericentromeric repeats [41]. Also,
DNA methylation recruits the methyl-binding domain
containing proteins (MBDs) and assembles histone
deacetylase multiprotein repressory complexes (MeCP1
and Mi2/NuRD) [42]. However, the dynamics of such his-
tone modifications might be more complex and flexible,
for the reason that DNA methylation brings about more
stable silencing of gene expression than histone modifica-
tions do.
Generally, histone modifications also undergo dynamic
changes during preimplantation development. From ferti-
lization to syngamy, acetylated lysine (H4ac), the methyl-
ated histones H3K4me and H3K9me2/3, H3K27me1,
H4K20me3 are discernable in the female PN [43-45].
These are associated with active chromatin states and with
repressive chromatin organization. Moreover, H3K9me3
is found in centromeric major satellites, whereas
H3K9me2 is found in minor satellites [44]. During forma-
tion of the male PN, the protamines begin to be
exchanged for highly acetylated histones [43]. However,
immediately afterwards the histone acetyl groups are sub-
stituted by monomethyl groups and H3K4me1,
H3K9me1 and H3K27me1 are detectable [46]. Moreover,
in contrast with the monomethylated histones, dimethyl-
ated and trimethylated histones appear later [44] (Fig. 1B)
(see review [26]). Meanwhile, the level of histone arginine
methylation (H4R3me and H3R17me), an activating
mark of gene expression, also decreases as lysine acetyl
modification does [47].
Specifically, histone modifications change in stage- and
cell type-specific manners and assume their roles as
switches of gene expression, by which gene expression can
be precisely controlled according to necessity. For exam-
ple, during differentiation Oct4 and nanog are silenced
progressively with the first step being H3K9 methylated
[48]. In the blastocyst, the ICM and trophectoderm have
different histone modification profiles [49]. H3K9
acetylation and heterochromatic histone methylation are
reestablished preferentially in the ICM. H3K27me1/2/3
can be detected in both cell lines but are more predomi-
nant in the ICM, and H3K27me2/3 only appears in the
inactive X chromosome in the trophectoderm [49].
H3K9me2/3 show even activity levels in the ICM and tro-
phectoderm and H3K9me3 marks heterochromatic foci
[49] (see review [26]). These differences result from the
different fate of ICM and trophectoderm. ICM and troph-
ectoderm have different gene expression profiles. There-
fore, their epigenetic profiles also differ accordingly for
precise control.
Genes related to histone modifications include HMTases
(e.g. G9a, ESET and Suv39h) [37], histone deacetylases
(e.g. HDAC1, HDAC2 and HDAC3) [50], etc. The
enzymes ESET and Suv39h both catalyze H3K9 methyla-
tion and build a binding site for HP1 (Heterochromatin
protein 1) to form heterochromatin, however Suv39h
specifies parental asymmetry in constitutive heterochro-
matin [51] and ESET goes further to be needed for main-
taining cell viability [52]. Additionally, although HDAC1
was found to be a major deacetylase in preimplantation
development and mainly functions as a H4K5 deacety-
lase, HDAC1 knockdown does not affect the global tran-
scription rate, suggesting its role for a subset of genes but
not all [53]. Other HDACs might also play some roles,
however there is little evidence yet. Histone acetylases and
deacetylases are also involved in the modification of chro-
matin along with ATP-dependent chromatin remodeling
protein complexes (SWI/SNF, ISWI and Mi-2/NuRD),
which alter histone/DNA interactions via ATP hydrolysis
to make DNA more accessible to various factors including
transcription factors (TFs) [54]. SRG3, Brg1 and Ini1 are
the three core subunits of the SWI/SNF complex. MaternalReproductive Biology and Endocrinology 2009, 7:59 http://www.rbej.com/content/7/1/59
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Brg1 was found to be a good candidate for being involved
in ZGA [55] as was SRG3, whose expression pattern was
found to parallel those of TFs such as Sp1 and TBP [56],
reinforcing the important roles of chromatin remodeling
protein complexes in preimplantation embryogenesis.
Histone modification reprogramming is more complex
than DNA methylation and no general model can be
drawn from the accessible experimental data so far. How-
ever, similar to DNA methylation, histone modification
changes dynamically during preimplantation develop-
ment in stage- and cell type-specific manners, which are
required for the precise regulation of gene expression. As
participants in histone modification, the histone acety-
lases and deacetylases are also involved in chromatin
remodeling and help to pave the path for various factors
to the DNA.
Histone variants
Histones are building blocks of nucleosomes, each con-
sisting of eight core histone proteins (two each of H3, H4,
H2A and H2B) to form an octamer [57]. In addition, his-
tone protein H1 functions as a linker [57]. A set of histone
variants has been found in mammals including H3 vari-
ant CENP-A [58], H3.3 [59] and H2A variant H2AZ [60].
CENP-A involves in the formation of the foundation for
kinetochore assembly [58]; H3.3 incorporation always
happens at active genes [59]; H2AZ functions in transcrip-
tional regulation and chromosomal segregation [60].
During preimplantation development, histone variants
also play important roles. Linker histone H1 has six vari-
ants in which H1o shows obvious difference from other
five termed somatic H1 subtypes [61]. H1o was reported
to be expressed in the oocyte and the role of somatic H1
declines during early cleavage stages, which may be
related to the establishment of regulated embryonic gene
expression [61]. For macroH2A, the maternal stock is
removed before syngamy and the embryo proceeds with
cell division until the 8-cell stage after which macroH2A
protein expression reappears and persists into the blasto-
cyst stage. MacroH2A was found to be largely related with
expression inhibition and the facultative heterochromatin
of inactive X chromosomes [62] while in contrast with
macroH2A, another histone variant, H2ABbd, which has a
role in facilitating transcription [63], is depleted [64]. The
emerging view from these studies is that histone variants
when deposited into the nucleosomes, provide a differen-
tiation of chromatin and add to the epigenetic regulation
of preimplantation development.
Noncoding RNAs
Since the discovery of the first miRNA in 1993 [65,66],
miRNAs have attracted tremendous interest. MiRNAs are
short ncRNAs with 20–24 nucleotides (nt) that regulate
gene expression either by cleaving target mRNAs or by
blocking mRNA translation. Since lin-4 was first identi-
fied in regulation of the developmental timing of cell fate
in larval stages of Caenorhabditis elegans [65,66], miR-
NAs have been shown to function in various stages of
development including preimplantation development.
During miRNA biogenesis, Dicer (ribonuclease type III)
functions to cleave pre-miRNAs into mature miRNAs [67]
and these are incorporated into a complex termed RNA-
induced silencing complex (RISC) in which proteins with
activities such as helicase, exonuclease and the protein
Argonaut (Ago) facilitating RNA recognition include.
RISC then goes on to degrade mRNAs or to block their
translation [68]. Dicer deficiency is lethal during mouse
embryogenesis, leading to a lack of detectable stem cells
and an acute loss of proliferation potential [69]. Ago2 is
required for development through the ZGA period. Dur-
ing ZGA, maternally-derived transcription products are
destroyed. This suggests that RNAi-mediated machinery
may be involved in the degradation of a proportion of
maternally-derived transcription products [70]. Evidence
also comes from recent microarray analysis [71], revealing
the expression pattern of miRNAs and their stage-specific
functions. In all, 97 miRNAs have been analyzed and can
be divided into stage-specific and non stage-specific
groups. During ZGA, miRNAs may mainly participate in
the degradation of maternal messages [71]. During
morula stage compaction, miRNAs may be mainly
involved in cell adhesion [71]. MiRNAs may also play
roles in differentiation during the blastocyst stage and a
cluster of miRNAs from miR-290 to miR-295 were found
to be embryonic stem (ES) cell-specific, which may be
associated with the maintenance of pluripotency [71].
Thus, function-specific miRNAs are expressed to fulfill the
needs of developmental processes and miRNAs, like other
genes, are correctly regulated temporally and spatially by
upstream regulators.
Besides short ncRNAs, long ncRNAs also conduct impor-
tant development events in their own ways [72,73]. Long
ncRNAs are involved in the development of the germline,
eye and brain. Though not yet clearly elucidated, there is
mounting evidence to show that they have major roles in
regulating epigenetic trajectories in animal development.
Recent results [74,75] confirm this idea further: GAL10-
ncRNA was found to be a modulator of methylation and
histone deacetylation in the yeast GAL gene cluster [74]
and GHRLOS, a ncRNA candidate, might have regulatory
and functional roles in the ghrelin hormone response
[75]. During preimplantation development, long ncRNAs
are involved in gene silencing [76] and gene imprinting
[77]. The Air ncRNA is required for allele-specific silencing
of Slc22a3, Slc22a2 and Igf2r genes in the mouse
(Slc22a3, Slc22a2 are organic cation transporter involved
in organ-specific transport of various molecules [78] and
Igf2r functions in lysosome biogenesis and growth sup-Reproductive Biology and Endocrinology 2009, 7:59 http://www.rbej.com/content/7/1/59
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pression [79]). It accumulates at the Slc22a3 promoter
and recruits H3K9 methyltransferase G9a to fulfill
imprinting [76]. Another mouse imprinted domain,
Kcnq1, is located on the distal arm of chromosome 7 and
contains several imprinted genes. Repression of these
genes is regulated by a non-coding antisense transcript,
Kcnq1ot1, which is paternally expressed, but maternally
repressed by DNA methylation derived from the oocyte.
The expression of Kcnq1ot1 then triggers repression [77].
This regulation pattern is largely similar to X chromosome
inactivation, in which the ncRNA Xist coats the X chromo-
some and inactivates it [80]. When initiated, both will
recruit other epigenetic elements and undergo further
silencing, which will be described in detail below.
X chromosome inactivation (XCI) and the Kcnq1 
imprinted domain
X chromosome activity changes dynamically during pre-
implantation development and its inactivation is a com-
bination of epigenetic events including DNA methylation,
histone modifications and RNA-mediated silencing (Fig.
2). In female embryos with two X chromosomes, the
paternally-derived X chromosome is inactivated during
cleavage stages and persists this status in the trophecto-
derm and subsequently in the placenta [81]. However, in
the ICM this inactivation reverses and after differentiation
one of the two X chromosomes is selected stochastically to
be inactivated [82]. XCI is triggered by a ncRNA Xist which
is transcribed from a key locus on X chromosome termed
the X inactivation centre (Xic) [83]. Xist has been found to
be negatively regulated by Tisx. Tisx, as its name indicates,
is also a ncRNA that is complementary to Xist. Besides,
Tisx is in turn regulated by Xite, a special upstream
enhancer of Tisx [84]. Several studies have shown that Tisx
transcription brings about changes to chromatin, which in
turn regulate Xist transcription. Furthermore, Tisx-regu-
lated Xist silencing seems to be initiated by changes in his-
tone modifications and to be maintained by Tisx-
dependent recruitment of Dnmt3a to the promoter of Xist
for stable silencing [85-87]. During random selection for
XCI, two X chromosomes crosstalk by pairing on their Xic
regions. This is mediated by Tsix and Xite and a choice is
then made via this process followed by initiation of XCI
[88,89]. A recent study shed some light on the initial
spread of XCI. A 1.6 kb ncRNA (RepA) was discovered
within Xist. It serves to usher polycomb repressive com-
plex 2 (PRC2), as the direct target of RepA, to the X chro-
mosome [90]. Moreover, the maintenance of silencing
might be mediated by PRCs (PRC1 and PRC2) [91],
which can lead to histone modification changes such as
H2A-K119 ubiquitination and H3K27 methylation. This
suggests that RepA serves to link initiation and mainte-
nance. In addition to the factors mentioned above
involved in the early maintenance of XCI, long-term
maintenance machinery should exist. This includes the
participating of histone variants (incorporation of
macroH2A) and de novo methylation of the promoters of
X-linked genes [91]. XCI is complicated as the inactivation
status changes dynamically and the epigenetic interac-
tions involved in different phases of XCI – initiation, short
and long-term maintenance of silencing status – also
change dynamically. Although XCI has been elucidated in
the whole, controversies still exist and many questions
still need to be answered. For example, X chromosome
crosstalk-pairing and random selection for active/inactive
X chromosome (Xa/Xi) may be earlier than previously
X chromosome inactivation and regulatory mechanisms Figure 2
X chromosome inactivation and regulatory mechanisms. (A) The Xic region of the X chromosome and several regu-
latory elements in this region. Xist loci encodes a ncRNA which mediates the initiation of XCI. Xist is negatively regulated by 
another ncRNA, Tisx, which is complementary to Xist. Xite is a special upstream enhancer of Tisx. (B) By pairing at the Xic 
region, X chromosomes communicate and counting, selecting are then undergone to make sure that only one X chromosome 
remains active. Xa, active X chromosome; Xi, inactive X chromosome. (C) Mechanisms from initiation of XCI to the short- 
and long-term maintenance of silencing status. After selection, Xist coats the Xi chromosome to initiate XCI. A ncRNA (RepA) 
then usher polycomb repressive complex 2 (PRC2) to the Xi chromosome, recruiting histone modification changes such as 
H2A-K119 ubiquitination (U) and H3K27 methylation (M). Histone modifications bring about short-term silencing followed by 
histone variant incorporation (macroH2A) and de novo DNA methylation, mediating long-term silencing.Reproductive Biology and Endocrinology 2009, 7:59 http://www.rbej.com/content/7/1/59
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proposed according to the recent studies [92,93]. And,
XCI may have another layer of regulation where both X-
silencing on Xi and X-upregulation on Xa are involved
[94,95].
As discussed above, the imprinting process of the mouse
Kcnq1 imprinted domain is almost similar to XCI.
Imprinting is initiated by a ncRNA Kcnq1ot1 from the 2-
cell stage during preimplantation development and is
maintained by altering the status of histone modifications
including H3Ac, H3K4me2, H3K9me2 and H3K27me3,
resulting in allele-specific (paternal) and region-specific
(placenta/embryo) gene silencing [77].
In conclusion, single epigenetic events (DNA methyla-
tion, histone modification, RNAi, etc.) are able to play
important roles as switches in the regulation of gene
expression, but they always interact to accomplish their
responsibilities. Combinations of several epigenetic
events have evolved to conduct even more complex silenc-
ing such as X chromosome inactivation and gene imprint-
ing, which makes it even more difficult to understand the
epigenetic regulation network. The status of epigenetic
modification should be examined, but this is not the end
of the task. The interactions and the hierarchies between
each event involved need to be determined carefully.
What is more, the dynamics of epigenetic regulation is
another area to be elucidated, as this is necessary for meas-
uring gene expression profiles.
Interactions between epigenetic and genetic regulation
Epigenetic regulation and genetic regulation are strictly
interrelated. On one hand, every epigenetic event needs
certain enzymes (e.g, Dnmts for DNA methylation,
HMTases and HDACs for histone modifications) or pro-
tein complexes (e.g, PRCs, MeCP1). Therefore, the expres-
sion of the main epigenetic participants should be
initiated and then epigenetic regulation could be on the
way. The expression pattern of some epigenetic partici-
pants are consistent with globe gene expression transition
(ZGA) while some are not. HDAC1 belongs to the former
ones, which initiates expression at the single cell stage and
its expression level increases gradually until the blastocyst
[53]. Eset belongs to the latter ones. Its expression will not
be initiated until the blastocyst stage when maternal ESET
becomes exhausted [52]. On the other hand, epigenetic
regulation always assumes its responsibility in coopera-
tion with genetic regulation. During preimplantation
development, the embryo will commence differentiating
into two parts, ICM and trophectoderm. ICM remains
Some examples of interactions between genetics and epigenetics Figure 3
Some examples of interactions between genetics and epigenetics. (A) The Ped gene protein product Qa-2 affects the 
level of an epigenetic element (miR-125a) to participate in the interaction. (B) The LINE-1(L1) retrotransposon expression is 
precisely regulated by epigenetic mechanisms (negatively by RNAi and positively by demethylation), while its expression and 
activation can effect gene expression both genetically and epigenetically. When genetically, large and short insertion cause elon-
gation disruption or attenuation. When epigenetically, expression of L1 disrupts or attenuates gene expression without inser-
tion. (C) Ronin (R) binds DNA directly; once bound it recruits HCF-1 (Hc) and other proteins that are related with 
transcriptional repression or histone modifications, among which are THAP7 (T), sin3A (S) and HDAC3 (Hd), to form a large 
protein complex and regulate histone modifications (methylation and deacetylation) so as to affect gene expression.Reproductive Biology and Endocrinology 2009, 7:59 http://www.rbej.com/content/7/1/59
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pluripotent and trophectoderm loses it. Therefore, Oct4,
as a key transcription factor of pluripotency, its expression
needs to be precisely regulated. Sall4 binds with the
enhancer of Oct4 and activates the expression of Oct4
[96], Tead4 controls the expression of the transcription
factor Caudal-related homeobox 2 (Cdx2) and then
impedes the expression of Oct4 [97]. Meanwhile, the sta-
tus of methylation and histone acetylation in the Oct4
enhancer/promoter is altered to regulate its expression
[98]. Oct4 also acts to promote the expression of another
key transcription factor of pluripotency, Nanog, by bind-
ing to the proximal region of Nanog promoter [99].
Nanog expression is also regulated epigenetically. In the
cells of ICM, histone H3 and H4 are highly acetylated and
H3K4 is hypermethylated at the Nanog locus [100].
Finally, epigenetic regulation is always interlaced with
genetic regulation in a hierarchy to form a regulatory net-
work. For example, the mouse preimplantation embryo
development (Ped) gene product, Qa-2 was recently
found to affect the level of miR-125a [101] which is
involved in the regulation of timing of early mouse
embryo development (Fig. 3A). This gives powerful evi-
dence of genetic and epigenetic interactions during preim-
plantation development in which LINE-1 retroposons
[102-104] and Ronin [105] are also involved. LINE-1 ret-
roposons expression is precisely controlled by epigenetic
events while LINE-1 can alter the gene expression level
both genetically and epigenetically [102-104] (Fig. 3B).
Ronin associates with DNA and then recruits some pro-
teins to alter the histone modification status [105] (Fig.
3C). Also, after fertilization, some maternally derived epi-
genetic participants remain and are involved in gene
expression transition, which alter the gene expression sta-
tus and combine with the newly expressed epigenetic par-
ticipants and other genes to further regulate the gene
expression and development (Fig. 4).
Conclusion
Preimplantation embryo development is a complex proc-
ess, which is regulated not only genetically but also epige-
netically. With the endeavor of several generations of
scientists, the code of the beginning of life has been deci-
phered gradually. Microarray analysis has broadened our
knowledge of gene expression profiles in the preimplanta-
tion embryo. Certain gene expression profiles help to
unravel the mystery of these developmental stages, which
further promote research on the epigenome. We are still in
the early exploratory stages of epigenomics. Studying the
epigenome is intriguing and important because minor
defects can lead to serious human diseases. Thus, several
syndromes are associated with imprinting defects during
preimplantation development [106-108]. Many aspects of
epigenomics are now understood and many exciting stud-
ies have been done including research on the methylome.
This is of significant clinical importance and can provide
some biomarkers of certain human diseases, especially
cancer [109]. Histone methylation is also important,
recent study [110] indicated that histone methylation can
be epigenetic mark for leukemia. Although a general
model of DNA methylation status has been built using the
mouse embryo model, is this a general paradigm or is the
changing pattern of DNA methylation species-specific?
Although the status of common histone modifications
has been examined, what about the others: do they play
key roles in these developmental stages? Although miR-
NAs and other longer ncRNAs are broadly related with
developmental events, there is little evidence on the exact
roles of certain ncRNA types. Moreover, more focus
should be put on the delineation of epigenetic pathways
and interaction, not just on single epigenetic event. We
need to examine the interactions between different epige-
netic events and the interactions between epigenetic regu-
lation and genetic regulation. Global profiling sometimes
cannot tell the whole truth, so single cell profiling is
essential to construct a molecular regulation blueprint
and help us in dealing with human diseases involving
imprinted genes.
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